Abingdon Health Plc(ABDX)
GBX --+0.00%
Reward53Moderate
Risk51Moderate
📊75%Data
Thin -34% profit margin · Revenue growing 37% YoY
ABDX
+0.0 · +0.00%
GBX · LSE
Abingdon Health Plc | Healthcare
Profitless Growth
Market Cap:20.40M
ℹ️
Reward Rating
53
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
51
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ABDX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: 19p.

What is Abingdon Health Plc?

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally.

ABDX · Verdict

Moderate reward · elevated risk

ABDX stands out on volatility and growth, but watch the cash flow signal.

Based on 88% data coverage

ABDX · Verdict

What’s working & what to watch

Strengths 2

  • Volatility95/100

    Top decile vs peers

  • Growth74/100

    Rev +43.8% CAGR · earnings -45.6%

Watchouts 2

  • Cash flow6/100

    -41% free-cash-flow margin

  • Profitability9/100

    -41% net margin · -51% ROE

Model-based scoring. For information only — not financial advice.

What is Abingdon Health Plc?

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 20.40M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (53)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap20.40M
P/E RatioN/A
Dividend YieldN/A
52 Week High11
52 Week Low5.1
Last AnnualJune
IPO DateN/A
IncorporatedUK
Shares Outstanding251M
No. of Employees129
IndustryDiagnostics & Research
ExchangeLSE
Beta0.02
CurrencyGBX · Reports in GBP